Cart
sales@molnova.com
Quetiapin
CAS No. 111974-69-7
Quetiapin ( —— )
Catalog No. M10429 CAS No. 111974-69-7
Quetiapine is indicated for the treatment of schizophrenia as well as for the treatment of acute manic episodes associated with bipolar I disorder.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 45 | In Stock |
|
| 50MG | 81 | In Stock |
|
| 100MG | 105 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameQuetiapin
-
NoteResearch use only, not for human use.
-
Brief DescriptionQuetiapine is indicated for the treatment of schizophrenia as well as for the treatment of acute manic episodes associated with bipolar I disorder.
-
DescriptionQuetiapine is indicated for the treatment of schizophrenia as well as for the treatment of acute manic episodes associated with bipolar I disorder. The antipsychotic effect of quetiapine is thought by some to be mediated through antagonist activity at dopamine and serotonin receptors. Specifically the D1 and D2 dopamine, the alpha 1 adrenoreceptor and alpha 2 adrenoreceptor, and 5-HT1A and 5-HT2 serotonin receptor subtypes are antagonized. Quetiapine also has an antagonistic effect on the histamine H1 receptor.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT; mAChR; Adrenergic Receptor; Dopamine; H1 receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number111974-69-7
-
Formula Weight383.51
-
Molecular FormulaC21H25N3O2S
-
Purity>98%(HPLC)
-
SolubilityDMSO: 36 mg/mL;Water: <1 mg/mL
-
SMILESOCCOCCN1CCN(CC1)C1=NC2=CC=CC=C2SC2=CC=CC=C12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nasrallah HA. Mol Psychiatry. 2008 Jan;13(1):27-35.
molnova catalog
related products
-
Lafutidine
Lafutidine, a newly developed histamine H(2)-receptor antagonist, inhibits gastric acid secretion.
-
YL0919
An orally active, dual 5-HT1A agonist and selective serotonin reuptake inhibitor with Ki of 0.19 nM and IC50 of 1.78 nM, respectively.
-
SEP-363856 hydrochlo...
SEP-363856 hydrochloride is an agent of orally active and CNS active psychotropic with a unique, non-D2/5-HT2A mechanism of action, exerts its antipsychotic-like effects, has the potential to treatment of schizophrenia. SEP-856 (10μM) specifically inhibits α2A, α2B, D2, 5-HT1A, 5-HT1B, 5-HT1D, 5-HT2A, 5-HT2B, 5-HT2C and 5-HT7> 50% receptor.
